Posted on:
Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics capabilities, with AGRF – the Australian Genome Research Facility – establishing a laboratory within the institute. The new lab is part of an exciting partnership between AGRF, the University of Sydney and the Kolling which will see a specialised team and
Category:
Posted on:
A heavy Christmas lunch, an argument or even smoke from a bushfire may seem harmless, but for people at risk of heart disease, they could be deadly. A new study is investigating how emotional stress, pollution, chest infections, and large meals can trigger heart attacks in vulnerable people, and importantly, how to manage those triggers
Posted on:
Royal North Shore Hospital’s Associate Professor Brendon Neuen will establish an international consortium to support those with both heart and kidney disease. The nephrologist and Director of Kidney Trials will lead the collaboration after being awarded close to $500,000 from NSW Health through a program to drive groundbreaking projects in heart disease. The grant will
Category:
Posted on:
We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop
Posted on:
In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who
Category:
Posted on:
We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s
Posted on:
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging significant new collaborations. They
Posted on:
A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one example of this is a joint project to reduce the devastating impact of vascular disease linked to diabetes. The study has brought together research experts from endocrinology and cardiology to curb the number of lower limb amputations due
Category: